Jubilant Pharmova Limited (NSE: JUBLPHARMA), ISIN INE700A01033 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JUBLPHARMA last traded at ₹965.75 (-1.24%), with a 52-week range of ₹783.75 to ₹1250.00 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 47.68%, FIIs 15.90%, DIIs 11.62%, mutual funds 8.03%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.